Key word is 'expected'. Things have happened on the FDA side that might have had an influence in the delay and have caused the review process to be longer than expected.
yup and now here we are with no end in sight. Fife will be lending us more money in short order which will confirm no end in sight and give him another chance of more equity down the line
Meanwhile, we have seen the change in the definition of GBM by the WHO last year. We have also read several articles on the FDA's move to RWE, evidence of a significant change in their View. And all this in the vein of NWBO.